Hydrocortisone in Severe Community-Acquired PneumoniaPierre‐François Dequin, Amélie Le Gouge, Jean‐Damien Ricard et al.|New England Journal of Medicine|2023Cited by 438
Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trialBruno François, Thorbjørn Grøfte, Simon Lambden et al.|The Lancet Respiratory Medicine|2023Cited by 76